Alignment Healthcare (ALHC)
Alignment Healthcare on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as hospital & medical service plans.
25.5M
Short interest
settlement 2026-10-15
2.3
Days to cover
+0.6 days vs prior
38.9%
Short share of volume
2026-10-28
615,856
Fails to deliver
settlement 2026-09-25
Thu 29 Oct
Next earnings
estimated date
-$13.7M
Insider flow, 90 days
0 buys, 8 sells
As of 2026-10-28.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in ALHC is 25,522,328 shares, up 904,250 shares over the last month. Over the last 48 readings it ranged from 3,767,974 shares (15 November 2024) to 25,522,328 shares (15 October 2026). The latest reading sits at the top of that range. At the reported average volume of 11.3M shares a day that is 2.3 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/alhc" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 25,522,328 | +8.1% | 11,333,373 | 2.25 |
| 2026-09-30 | 23,606,597 | -4.1% | 14,644,166 | 1.61 |
| 2026-09-15 | 24,618,078 | +7.8% | 6,962,722 | 3.54 |
| 2026-08-31 | 22,837,600 | -3.0% | 3,782,281 | 6.04 |
| 2026-08-14 | 23,534,830 | +6.8% | 6,544,092 | 3.60 |
| 2026-07-31 | 22,045,849 | -11.2% | 4,778,836 | 4.61 |
| 2026-07-15 | 24,812,050 | +1.8% | 5,318,097 | 4.67 |
| 2026-06-30 | 24,365,170 | -4.1% | 5,142,275 | 4.74 |
| 2026-06-15 | 25,417,994 | -0.1% | 8,125,898 | 3.13 |
| 2026-05-29 | 25,436,308 | +1.4% | 3,456,550 | 7.36 |
| 2026-05-15 | 25,081,336 | +55.6% | 9,241,593 | 2.71 |
| 2026-04-30 | 16,119,223 | -4.9% | 3,296,502 | 4.89 |
| 2026-04-15 | 16,956,196 | +3.5% | 3,776,773 | 4.49 |
| 2026-03-31 | 16,375,076 | +3.0% | 3,046,615 | 5.37 |
| 2026-03-13 | 15,897,618 | -0.1% | 3,478,906 | 4.57 |
| 2026-02-27 | 15,920,705 | -0.8% | 2,413,945 | 6.60 |
| 2026-02-13 | 16,055,036 | -1.0% | 2,211,407 | 7.26 |
| 2026-01-30 | 16,214,863 | -6.2% | 3,391,064 | 4.78 |
| 2026-01-15 | 17,293,251 | +12.3% | 2,736,810 | 6.32 |
| 2025-12-31 | 15,400,913 | -4.0% | 2,735,664 | 5.63 |
| 2025-12-15 | 16,037,111 | +5.3% | 2,638,577 | 6.08 |
| 2025-11-28 | 15,223,105 | +8.9% | 2,660,382 | 5.72 |
| 2025-11-14 | 13,982,386 | +1.6% | 1,953,666 | 7.16 |
| 2025-10-31 | 13,767,170 | +0.8% | 2,546,061 | 5.41 |
| 2025-10-15 | 13,661,380 | -4.7% | 2,926,344 | 4.67 |
| 2025-09-30 | 14,327,958 | +11.5% | 3,870,710 | 3.70 |
| 2025-09-15 | 12,854,317 | +6.7% | 4,963,334 | 2.59 |
| 2025-08-29 | 12,051,970 | -0.1% | 2,620,439 | 4.60 |
| 2025-08-15 | 12,063,140 | -10.5% | 3,107,613 | 3.88 |
| 2025-07-31 | 13,476,373 | +1.6% | 4,350,906 | 3.10 |
| 2025-07-15 | 13,268,490 | +5.2% | 3,107,088 | 4.27 |
| 2025-06-30 | 12,618,961 | +24.6% | 3,364,049 | 3.75 |
| 2025-06-13 | 10,130,059 | +3.8% | 2,662,727 | 3.80 |
| 2025-05-30 | 9,760,558 | +9.8% | 3,451,190 | 2.83 |
| 2025-05-15 | 8,888,253 | -14.5% | 4,280,111 | 2.08 |
| 2025-04-30 | 10,395,565 | -0.8% | 2,862,261 | 3.63 |
| 2025-04-15 | 10,482,265 | +10.3% | 3,996,191 | 2.62 |
| 2025-03-31 | 9,501,930 | +14.9% | 2,562,360 | 3.71 |
| 2025-03-14 | 8,266,768 | +17.3% | 2,783,208 | 2.97 |
| 2025-02-28 | 7,050,837 | -13.2% | 2,328,440 | 3.03 |
| 2025-02-14 | 8,119,817 | +0.8% | 1,541,003 | 5.27 |
| 2025-01-31 | 8,054,907 | -13.2% | 1,999,805 | 4.03 |
| 2025-01-15 | 9,277,573 | -3.1% | 1,822,280 | 5.09 |
| 2024-12-31 | 9,577,322 | +2.4% | 1,442,001 | 6.64 |
| 2024-12-13 | 9,352,640 | -15.8% | 1,796,357 | 5.21 |
| 2024-11-29 | 11,110,055 | +194.8% | 2,076,978 | 5.35 |
| 2024-11-15 | 3,767,974 | -16.4% | 2,583,394 | 1.46 |
| 2024-10-31 | 4,508,811 | +2.0% | 1,209,924 | 3.73 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 28 October 2026, the short share of ALHC volume is 38.9%, down 17.1 points over the last five sessions. Over the last 30 readings it ranged from 19.9% (24 September 2026) to 56.0% (21 October 2026). The latest reading is 2.9 points above the 30-session average of 36.0%, on 1.7M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-28 | 650K | 1.7M | 38.9% | 0 |
| 2026-10-27 | 561K | 1.9M | 29.5% | 62 |
| 2026-10-26 | 567K | 1.6M | 34.6% | 1,513 |
| 2026-10-23 | 789K | 1.9M | 42.1% | 0 |
| 2026-10-22 | 560K | 1.1M | 49.6% | 7 |
| 2026-10-21 | 608K | 1.1M | 56.0% | 2,150 |
| 2026-10-20 | 264K | 911K | 29.0% | 0 |
| 2026-10-19 | 483K | 1.2M | 39.5% | 0 |
| 2026-10-16 | 722K | 1.8M | 39.3% | 0 |
| 2026-10-15 | 987K | 2.8M | 34.9% | 2,962 |
| 2026-10-14 | 1.1M | 3.3M | 33.6% | 188,278 |
| 2026-10-13 | 920K | 2.3M | 40.8% | 1 |
| 2026-10-12 | 1.7M | 4.7M | 35.3% | 81,315 |
| 2026-10-09 | 3.6M | 11.1M | 32.6% | 356,630 |
| 2026-10-08 | 1.1M | 2.3M | 46.4% | 187 |
| 2026-10-07 | 1.0M | 2.6M | 38.6% | 6 |
| 2026-10-06 | 2.3M | 5.5M | 42.0% | 57,238 |
| 2026-10-05 | 1.0M | 4.6M | 22.8% | 0 |
| 2026-10-02 | 651K | 3.0M | 21.7% | 60 |
| 2026-10-01 | 1.8M | 6.4M | 27.4% | 1,670 |
| 2026-09-30 | 1.6M | 3.8M | 42.7% | 160,800 |
| 2026-09-29 | 1.0M | 2.3M | 43.8% | 300 |
| 2026-09-28 | 1.5M | 3.1M | 49.4% | 796 |
| 2026-09-25 | 1.3M | 4.4M | 30.0% | 5,724 |
| 2026-09-24 | 1.7M | 8.6M | 19.9% | 80,550 |
| 2026-09-23 | 2.7M | 8.4M | 32.2% | 301,264 |
| 2026-09-22 | 1.6M | 6.3M | 24.6% | 13,004 |
| 2026-09-21 | 1.6M | 6.0M | 27.5% | 16,087 |
| 2026-09-18 | 3.4M | 9.6M | 35.0% | 10,403 |
| 2026-09-17 | 5.1M | 12.9M | 39.7% | 171,003 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 25 September 2026, the fails-to-deliver balance in ALHC is 615,856 shares, up 614,856 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (8 April 2026) to 615,856 shares (25 September 2026). The latest reading sits at the top of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-25 | 615,856 | $7.67 | $4.7M |
| 2026-09-16 | 1,000 | $10.37 | $10K |
| 2026-09-14 | 434,372 | $12.61 | $5.5M |
| 2026-08-31 | 106 | $13.62 | $1K |
| 2026-08-21 | 5,527 | $12.93 | $71K |
| 2026-08-13 | 8,735 | $13.52 | $118K |
| 2026-08-04 | 48,527 | $14.56 | $707K |
| 2026-08-03 | 55,809 | $14.85 | $829K |
| 2026-07-24 | 37 | $20.00 | $740 |
| 2026-07-20 | 843 | $20.60 | $17K |
| 2026-07-02 | 7,601 | $24.01 | $183K |
| 2026-06-23 | 2 | $21.29 | $43 |
| 2026-06-22 | 2,887 | $21.86 | $63K |
| 2026-06-18 | 70,885 | $21.42 | $1.5M |
| 2026-06-17 | 14 | $20.60 | $288 |
| 2026-06-16 | 1,532 | $19.78 | $30K |
| 2026-06-15 | 295 | $19.75 | $6K |
| 2026-06-12 | 966 | $20.24 | $20K |
| 2026-06-10 | 686 | $19.20 | $13K |
| 2026-06-05 | 94 | $15.07 | $1K |
| 2026-06-04 | 61,179 | $14.25 | $872K |
| 2026-05-20 | 1,338 | $16.36 | $22K |
| 2026-05-14 | 55,048 | $18.27 | $1.0M |
| 2026-05-05 | 4,800 | $19.26 | $92K |
| 2026-04-22 | 10 | $21.56 | $216 |
| 2026-04-16 | 3 | $20.92 | $63 |
| 2026-04-15 | 69 | $21.28 | $1K |
| 2026-04-08 | 2 | $21.66 | $43 |
| 2026-03-09 | 57,558 | $18.44 | $1.1M |
| 2026-03-06 | 7,055 | $18.57 | $131K |
Insider trades
SEC Form 4, newest first. JSONInsiders at ALHC reported 8 open-market sells worth $13.7M in the last 90 days and no open-market buys. Latest filing: Kim Hyong (Chief Medical Officer) on 2026-10-06.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Kim Hyong | Chief Medical Officer | Sell | 32K | $8.30 | $270K | 299K |
| 2026-09-17 | KONOWIECKI JOSEPH S | EVP, Corporate Affairs | Sell | 24K | $8.61 | $202K | 1.1M |
| 2026-09-14 | KAO JOHN E | Chief Executive Officer | Sell | 27K | $13.00 | $356K | 591K |
| 2026-09-11 | Maroney Dawn Christine | President | Sell | 123K | $12.68 | $1.6M | 795K |
| 2026-09-11 | KAO JOHN E | Chief Executive Officer | Sell | 385K | $12.68 | $4.9M | 1.2M |
| 2026-09-10 | KAO JOHN E | Chief Executive Officer | Sell | 173K | $12.96 | $2.2M | 618K |
| 2026-08-14 | Maroney Dawn Christine | President | Sell | 5K | $14.00 | $70K | 917K |
| 2026-08-10 | KAO JOHN E | Chief Executive Officer | Sell | 298K | $13.88 | $4.1M | 791K |
| 2026-07-15 | Maroney Dawn Christine | President | Sell | 177K | $20.83 | $3.7M | 922K |
| 2026-07-15 | Maroney Dawn Christine | President | Exercise or conversion | 152K | $9.06 | $1.4M | 1.1M |
| 2026-07-10 | KAO JOHN E | Chief Executive Officer | Sell | 18K | $20.65 | $379K | 1.1M |
| 2026-07-10 | KAO JOHN E | Chief Executive Officer | Sell | 280K | $19.81 | $5.5M | 1.1M |
| 2026-07-01 | Hochradel Shane J. | Chief Operations Officer | Grant | 88K | $0.00 | $0 | 88K |
| 2026-07-01 | KONOWIECKI JOSEPH S | EVP, Corporate Affairs | Sell | 25K | $24.00 | $600K | 1.1M |
| 2026-06-26 | KONOWIECKI JOSEPH S | EVP, Corporate Affairs | Sell | 25K | $23.00 | $575K | 1.1M |
| 2026-06-18 | KONOWIECKI JOSEPH S | EVP, Corporate Affairs | Sell | 25K | $22.00 | $550K | 1.2M |
| 2026-06-15 | Maroney Dawn Christine | President | Sell | 30K | $19.55 | $586K | 947K |
| 2026-06-12 | Kim Hyong | Chief Medical Officer | Sell | 36K | $19.86 | $714K | 332K |
| 2026-06-11 | KONOWIECKI JOSEPH S | EVP, Corporate Affairs | Sell | 25K | $21.00 | $525K | 1.2M |
| 2026-06-10 | KAO JOHN E | Chief Executive Officer | Sell | 223K | $20.60 | $4.6M | 1.4M |
| 2026-06-10 | KAO JOHN E | Chief Executive Officer | Sell | 75K | $19.65 | $1.5M | 1.6M |
| 2026-06-03 | Kent Mark D. | President - MSO | Grant | 88K | $0.00 | $0 | 103K |
| 2026-06-03 | KONOWIECKI JOSEPH S | EVP, Corporate Affairs | Grant | 123K | $0.00 | $0 | 1.2M |
| 2026-06-02 | Kent Mark D. | President - MSO | Buy | 15K | $13.31 | $198K | 15K |
| 2026-05-18 | Maroney Dawn Christine | President | Gift | 20K | $0.00 | $0 | 977K |
| 2026-05-15 | Maroney Dawn Christine | President | Gift | 2K | $0.00 | $0 | 997K |
| 2026-05-15 | Maroney Dawn Christine | President | Sell | 30K | $16.09 | $483K | 999K |
| 2026-05-11 | KAO JOHN E | Chief Executive Officer | Sell | 17K | $17.54 | $300K | 1.5M |
| 2026-05-11 | KAO JOHN E | Chief Executive Officer | Sell | 281K | $16.85 | $4.7M | 1.5M |
| 2026-04-15 | Maroney Dawn Christine | President | Sell | 30K | $20.87 | $626K | 1.0M |
| 2026-04-13 | KAO JOHN E | Chief Executive Officer | Sell | 82K | $20.80 | $1.7M | 1.8M |
| 2026-04-10 | KAO JOHN E | Chief Executive Officer | Sell | 14K | $21.38 | $295K | 1.9M |
| 2026-04-10 | KAO JOHN E | Chief Executive Officer | Sell | 202K | $20.58 | $4.2M | 1.9M |
| 2026-04-07 | Head James M | Chief Financial Officer | Sell | 11K | $21.08 | $234K | 173K |
| 2026-04-07 | KAO JOHN E | Chief Executive Officer | Sell | 118K | $21.40 | $2.5M | 2.1M |
| 2026-04-07 | KAO JOHN E | Chief Executive Officer | Sell | 132K | $20.67 | $2.7M | 2.2M |
| 2026-04-01 | JOYCE CHRISTOPHER J | Chief Legal and Admin. Officer | Sell | 18K | $17.79 | $320K | 305K |
| 2026-03-23 | KAO JOHN E | Chief Executive Officer | Sell | 118K | $17.48 | $2.1M | 2.4M |
| 2026-03-19 | Wagner Andreas P. | Chief Human Resources Officer | Sell | 12K | $18.22 | $211K | 149K |
| 2026-03-18 | Burzacchi Sebastian | COO - Mgmt Services Org | Sell | 15K | $17.84 | $274K | 259K |
| 2026-03-18 | Kim Hyong | Chief Medical Officer | Sell | 18K | $17.84 | $328K | 368K |
| 2026-03-18 | JOYCE CHRISTOPHER J | Chief Legal and Admin. Officer | Sell | 25K | $17.84 | $448K | 323K |
| 2026-03-18 | Maroney Dawn Christine | President | Sell | 37K | $17.84 | $656K | 1.1M |
| 2026-03-18 | KAO JOHN E | Chief Executive Officer | Sell | 73K | $17.84 | $1.3M | 1.8M |
| 2026-03-18 | Scavo Robert L. | Chief Information Officer | Sell | 11K | $17.84 | $201K | 488K |
| 2026-03-18 | Wagner Andreas P. | Chief Human Resources Officer | Sell | 12K | $17.84 | $214K | 160K |
| 2026-03-16 | Maroney Dawn Christine | President | Sell | 30K | $17.48 | $524K | 1.1M |
| 2026-03-13 | Wagner Andreas P. | Chief Human Resources Officer | Grant | 24K | $0.00 | $0 | 172K |
| 2026-03-13 | Burzacchi Sebastian | COO - Mgmt Services Org | Grant | 36K | $0.00 | $0 | 274K |
| 2026-03-13 | Mansour Adnan R. | Chief Digital Officer | Grant | 25K | $0.00 | $0 | 48K |
| 2026-03-13 | JOYCE CHRISTOPHER J | Chief Legal and Admin. Officer | Grant | 52K | $0.00 | $0 | 349K |
| 2026-03-13 | Kim Hyong | Chief Medical Officer | Grant | 53K | $0.00 | $0 | 386K |
| 2026-03-13 | Head James M | Chief Financial Officer | Grant | 103K | $0.00 | $0 | 185K |
| 2026-03-13 | Maroney Dawn Christine | President | Grant | 162K | $0.00 | $0 | 1.1M |
| 2026-03-13 | KAO JOHN E | Chief Executive Officer | Grant | 338K | $0.00 | $0 | 1.9M |
| 2026-03-13 | Vorhoff Nicholas Robbert | Director | Grant | 19K | $0.00 | $0 | 173K |
| 2026-03-13 | McClellan Mark B. | Director | Grant | 13K | $0.00 | $0 | 371K |
| 2026-03-13 | McCarthy Margaret M | Director | Grant | 14K | $0.00 | $0 | 144K |
| 2026-03-13 | KOSECOFF JACQUELINE B | Director | Grant | 13K | $0.00 | $0 | 304K |
| 2026-03-13 | KONOWIECKI JOSEPH S | Director | Grant | 25K | $0.00 | $0 | 1.1M |
| 2026-03-13 | JORDEN YON | Director | Grant | 13K | $0.00 | $0 | 106K |
| 2026-03-13 | HODGSON DAVID C | Director | Grant | 19K | $0.00 | $0 | 173K |
| 2026-03-13 | BILNEY JODY L | Director | Grant | 16K | $0.00 | $0 | 129K |
| 2026-03-12 | Scavo Robert L. | Chief Information Officer | Sell | 245 | $16.99 | $4K | 499K |
| 2026-03-12 | Scavo Robert L. | Chief Information Officer | Sell | 4K | $17.48 | $66K | 499K |
| 2026-03-12 | Maroney Dawn Christine | President | Sell | 2K | $16.99 | $30K | 964K |
| 2026-03-12 | Maroney Dawn Christine | President | Sell | 27K | $17.48 | $478K | 965K |
| 2026-03-12 | KAO JOHN E | Chief Executive Officer | Sell | 3K | $16.99 | $50K | 1.5M |
| 2026-03-12 | KAO JOHN E | Chief Executive Officer | Sell | 46K | $17.48 | $803K | 1.5M |
| 2026-03-10 | KAO JOHN E | Chief Executive Officer | Sell | 180K | $18.19 | $3.3M | 2.5M |
| 2026-03-10 | Maroney Dawn Christine | President | Gift | 4K | $0.00 | $0 | 993K |
| 2026-03-04 | Wagner Andreas P. | Chief Human Resources Officer | Sell | 21K | $18.62 | $393K | 149K |
| 2026-02-23 | Mansour Adnan R. | Chief Digital Officer | Grant | 23K | $0.00 | $0 | 23K |
| 2026-02-17 | Maroney Dawn Christine | President | Sell | 30K | $20.63 | $619K | 997K |
| 2026-02-10 | Wagner Andreas P. | Chief Human Resources Officer | Sell | 22K | $20.47 | $455K | 170K |
| 2026-02-10 | KAO JOHN E | Chief Executive Officer | Sell | 180K | $20.49 | $3.7M | 2.7M |
| 2026-01-15 | Maroney Dawn Christine | President | Sell | 15K | $22.78 | $339K | 1.0M |
| 2026-01-15 | Maroney Dawn Christine | President | Sell | 15K | $22.19 | $336K | 1.0M |
| 2026-01-12 | KAO JOHN E | Chief Executive Officer | Sell | 3K | $21.57 | $59K | 2.8M |
| 2026-01-12 | KAO JOHN E | Chief Executive Officer | Sell | 177K | $21.10 | $3.7M | 2.8M |
| 2026-01-06 | Kim Hyong | Chief Medical Officer | Sell | 17K | $21.35 | $352K | 333K |
| 2026-01-06 | Maroney Dawn Christine | President | Sell | 228K | $21.33 | $4.9M | 1.1M |
| 2026-01-02 | JOYCE CHRISTOPHER J | Chief Legal and Admin. Officer | Sell | 11K | $20.03 | $213K | 297K |
| 2026-01-02 | Maroney Dawn Christine | President | Sell | 100K | $20.03 | $2.0M | 1.3M |
| 2025-12-29 | Scavo Robert L. | Chief Information Officer | Sell | 4K | $19.38 | $74K | 503K |
| 2025-12-29 | Scavo Robert L. | Chief Information Officer | Sell | 66K | $18.71 | $1.2M | 507K |
| 2025-12-29 | Kim Hyong | Chief Medical Officer | Sell | 696 | $19.38 | $13K | 350K |
| 2025-12-29 | Kim Hyong | Chief Medical Officer | Sell | 12K | $18.71 | $224K | 350K |
| 2025-12-29 | KAO JOHN E | Chief Executive Officer | Sell | 33K | $19.38 | $644K | 2.2M |
| 2025-12-29 | KAO JOHN E | Chief Executive Officer | Sell | 572K | $18.71 | $10.7M | 2.3M |
| 2025-12-29 | Maroney Dawn Christine | President | Sell | 15K | $19.38 | $300K | 1.4M |
| 2025-12-29 | Maroney Dawn Christine | President | Sell | 267K | $18.71 | $5.0M | 1.4M |
| 2025-12-29 | JOYCE CHRISTOPHER J | Chief Legal and Admin. Officer | Sell | 888 | $19.38 | $17K | 308K |
| 2025-12-29 | JOYCE CHRISTOPHER J | Chief Legal and Admin. Officer | Sell | 15K | $18.71 | $286K | 309K |
| 2025-12-15 | Maroney Dawn Christine | President | Sell | 113K | $20.01 | $2.3M | 1.7M |
| 2025-12-12 | GENERAL ATLANTIC GENPAR, L.P. | TenPercentOwner | Sell | 11.1M | $18.57 | $206.5M | 13.5M |
| 2025-12-12 | General Atlantic (ALN HLTH), L.P. | 10% owner | Sell | 11.1M | $18.57 | $206.5M | 13.5M |
| 2025-12-12 | GENERAL ATLANTIC, L.P. | 10% owner | Sell | 11.1M | $18.57 | $206.5M | 13.5M |
| 2025-12-12 | Maroney Dawn Christine | President | Sell | 17K | $20.02 | $334K | 1.8M |
| 2025-12-10 | Burzacchi Sebastian | COO - Mgmt Services Org | Sell | 13K | $19.26 | $242K | 238K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON45 Form 144 notices on file for ALHC worth $310.5M at the prices reported; 2 in the last 90 days worth $6.6M. Latest: JEK TRUST U/A DTD 02/08/2021 filed on 2026-09-10 to sell 500,000 shares ($6.5M) from 2026-09-10.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-10 | JEK TRUST U/A DTD 02/08/2021Director, Officer | 500K | $6.5M | 0.241% | 2026-09-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-14 | DAWN MARONEYOfficer | 5K | $67K | 0.002% | 2026-08-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-15 | DAWN MARONEYOfficer | 177K | $3.8M | 0.086% | 2026-07-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-10 | JEK TRUST U/A DTD 02/08/2021Director, Officer | 596K | $12.5M | 0.288% | 2026-07-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-12 | HYONG J KIMOfficer | 36K | $728K | 0.017% | 2026-06-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-12 | SEBASTIAN BURZACCHIOfficer | 1K | $23K | 0.001% | 2026-06-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-11 | JEK TRUST U/A DTD 02/08/2021Director, Officer | 596K | $10.7M | 0.288% | 2026-05-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-15 | DAWN MARONEYOfficer | 90K | $1.9M | 0.044% | 2026-04-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-07 | JEK TRUST U/A DTD 02/08/2021Director, Officer | 548K | $10.2M | 0.268% | 2026-04-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-06 | James M. HeadChief Financial Officer | 12K | $224K | 0.006% | 2026-04-07 | E-Trade Finance |
| 2026-04-01 | Christopher JoyceOfficer | 18K | $317K | 0.009% | 2026-04-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-23 | JEK TRUST U/A DTD 02/08/2021Director, Officer | 118K | $2.0M | 0.058% | 2026-03-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-19 | ANDREAS WAGNEROfficer | 12K | $211K | 0.006% | 2026-03-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-16 | Hyong (Ken) Kim, M.D.Chief Medical Officer | 39K | $659K | 0.019% | 2026-03-18 | E-Trade Finance |
| 2026-03-16 | Sebastian BurzacchiChief Operating Officer - MSO | 17K | $289K | 0.008% | 2026-03-18 | E-Trade Finance |
| 2026-03-16 | Christopher JoyceChief Legal & Administrative Officer | 28K | $469K | 0.014% | 2026-03-18 | E-Trade Finance |
| 2026-03-16 | Dawn C. MaroneyPresident | 41K | $691K | 0.020% | 2026-03-18 | E-Trade Finance |
| 2026-03-16 | John KaoChief Executive Officer | 81K | $1.4M | 0.040% | 2026-03-18 | E-Trade Finance |
| 2026-03-16 | Andreas P. WagnerChief Human Resources Officer | 13K | $225K | 0.006% | 2026-03-18 | E-Trade Finance |
| 2026-03-16 | Robert L. ScavoChief Information Officer | 12K | $206K | 0.006% | 2026-03-18 | E-Trade Finance |
| 2026-03-10 | JEK TRUST U/A DTD 02/08/2021Director, Officer | 180K | $3.3M | 0.088% | 2026-03-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-10 | Robert L. ScavoChief Information Officer | 4K | $76K | 0.002% | 2026-03-11 | E-Trade Finance |
| 2026-03-10 | Dawn MaroneyPresident | 30K | $553K | 0.015% | 2026-03-11 | E-Trade Finance |
| 2026-03-10 | John KaoChief Executive Officer | 50K | $922K | 0.024% | 2026-03-11 | E-Trade Finance |
| 2026-03-04 | ANDREAS WAGNEROfficer | 21K | $390K | 0.010% | 2026-03-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-09 | Andreas WagnerChief Human Resources Officer | 23K | $489K | 0.011% | 2026-02-10 | E-Trade Finance |
| 2026-01-06 | DAWN MARONEYOfficer | 318K | $6.7M | 0.159% | 2026-01-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-06 | HYONG J KIMOfficer | 17K | $347K | 0.008% | 2026-01-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-23 | Robert ScavoChief Information Officer | 68K | $1.4M | 0.034% | 2025-12-24 | E-Trade Finance |
| 2025-12-23 | Christopher JoyceChief Legal & Admin. Officer | 15K | $303K | 0.007% | 2025-12-24 | E-Trade Finance |
| 2025-12-23 | Dawn MaroneyPresident | 275K | $5.6M | 0.137% | 2025-12-24 | E-Trade Finance |
| 2025-12-23 | John KaoChief Executive Officer | 600K | $12.1M | 0.300% | 2025-12-24 | E-Trade Finance |
| 2025-12-23 | Hyong (Ken) Kim, M.D.Chief Medical Officer | 13K | $262K | 0.006% | 2025-12-24 | E-Trade Finance |
| 2025-12-15 | DAWN MARONEYOfficer | 213K | $4.1M | 0.107% | 2025-12-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-12 | DAWN MARONEYOfficer | 17K | $324K | 0.008% | 2025-12-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-11 | Sebastian BurzacchiChief Operating Officer - MSO | 13K | $242K | 0.006% | 2025-12-10 | E-Trade Finance |
| 2025-12-10 | JEK TRUST U/A DTD 02/08/2021Director, Officer | 540K | $10.4M | 0.270% | 2025-12-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-10 | General Atlantic (ALN HLTH), L.P.Affiliate | 11.1M | $206.5M | 5.557% | 2025-12-10 | Morgan Stanley & Co. LLC |
| 2025-12-08 | CHRISTOPHER J. JOYCEOfficer | 30K | $593K | 0.015% | 2025-12-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-25 | Joseph KonowieckiDirector | 25K | $475K | 0.013% | 2025-11-25 | Merrill Lynch |
| 2025-11-10 | Joseph KonowieckiDirector | 5K | $82K | 0.002% | 2025-11-11 | E-Trade Finance |
| 2025-10-28 | Joseph KonowieckiDirector | 25K | $450K | 0.013% | 2025-10-28 | Merrill Lynch |
| 2025-10-09 | HYONG J KIMOfficer | 51K | $909K | 0.026% | 2025-10-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-08 | Hyong (Ken) KimChief Medical Officer | 36K | $603K | 0.018% | 2025-10-08 | E-Trade Finance |
| 2025-09-15 | Joseph KonowieckiDirector | 18K | $289K | 0.009% | 2025-09-16 | E-Trade Finance |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON11 holders report 5% or more of ALHC in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 11.3% of the class (23,530,373 shares), filed 2026-10-05 for an event on 2026-09-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-05 | 13G/Ano. 3 | BlackRock, Inc.parent holding company | 23.5M | 11.3% | 2026-09-30 |
| 2026-08-13 | 13G | Invesco Ltd.parent holding company, investment adviser | 10.4M | 5.0% | 2026-06-30 |
| 2026-07-31 | 13G | Vanguard Portfolio Managementinvestment adviser | 11.9M | 5.7% | 2026-06-30 |
| 2026-05-15 | 13G/Ano. 5 | GENERAL ATLANTIC, L.P.partnership | 309K | 0.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 5 | General Atlantic Partners 95, L.P.partnership | 309K | 0.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 5 | GAPCO GmbH & Co. KGother entity | 309K | 0.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 5 | GAP Coinvestments III, LLCother entity | 309K | 0.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 5 | GAP Coinvestments IV, LLCother entity | 309K | 0.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 5 | GAP Coinvestments V, LLCother entity | 309K | 0.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 5 | GAP Coinvestments CDA, L.P.partnership | 309K | 0.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 5 | General Atlantic (SPV) GP, LLCother entity | 309K | 0.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 5 | GAPCO Management GmbHcorporation | 309K | 0.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 5 | General Atlantic GenPar, L.P.partnership | 309K | 0.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 5 | General Atlantic (ALN HLTH), L.P.partnership | 309K | 0.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | Wellington Management Group LLPparent holding company | 17.1M | 8.4% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | Wellington Group Holdings LLPparent holding company | 17.1M | 8.4% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | Wellington Investment Advisors Holdings LLPparent holding company | 17.1M | 8.4% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | Wellington Management Company LLPinvestment adviser | 17.1M | 7.8% | 2026-03-31 |
| 2026-03-26 | 13G/Ano. 4 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-05 | 13G | FMR LLCparent holding company | 14.8M | 7.7% | 2025-12-31 |
| 2026-02-05 | 13G | Abigail P. Johnsonindividual | 14.8M | 7.7% | 2025-12-31 |
| 2025-11-14 | 13G/Ano. 1 | Kenneth Griffinparent holding company, individual | 6.7M | 3.4% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Citadel Advisors Holdings LPparent holding company, partnership | 6.0M | 3.0% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Citadel Advisors LLCinvestment adviser, parent holding company, other entity | 6.0M | 3.0% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Citadel GP LLCparent holding company, other entity | 6.0M | 3.0% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Citadel Securities Group LPparent holding company, partnership | 767K | 0.4% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Citadel Securities GP LLCparent holding company, other entity | 767K | 0.4% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Citadel Securities LLCbroker-dealer, other entity | 696K | 0.4% | 2025-09-30 |
| 2025-09-24 | 13G | Q Healthcare Holding LLCinvestment company | 13.2M | 6.7% | 2025-09-17 |
| 2025-09-24 | 13G | Qatar Investment Authorityother entity | 13.2M | 6.7% | 2025-09-17 |
13F holders
Tracked managers holding ALHC at their latest 13F. JSON5 of the 30 tracked managers held ALHC at their latest 13F, $105.5M in total at quarter-end prices. Millennium Management is the largest at $34.8M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 1.5M | $34.8M | 0.01% | -2.4M |
| Renaissance Technologies | 2026-06-30 | 998K | $23.8M | 0.03% | -1.9M |
| D. E. Shaw & Co. | 2026-06-30 | 855K | $20.4M | 0.01% | +742K |
| AQR Capital Management | 2026-06-30 | 594K | $14.1M | 0.00% | -224K |
| Two Sigma Investments | 2026-06-30 | 519K | $12.4M | 0.01% | +54K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Alignment Healthcare reported revenue of $1.34B, up 31.6% from the same quarter a year earlier, and net income of $36.6M (0.17 diluted EPS). In FY 2025 it generated $139.9M of operating cash flow. As of 2026-06-30, cash was $693.5M against $324.1M of debt.
- Cash
- $693.5M
- Debt
- $324.1M
- Equity
- $265.1M
- Total assets
- $1.28B
- Shares outstanding
- 207,435,149
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $1.34B | $36.6M | 2.7% | 0.17 |
| Q1 FY 2026 | 2026-03-31 | $1.24B | $11.4M | 0.9% | 0.05 |
| Q4 FY 2025derived | 2025-12-31 | $1.01B | -$11.0M | -1.1% | n/a |
| Q3 FY 2025 | 2025-09-30 | $993.7M | $3.7M | 0.4% | 0.02 |
| Q2 FY 2025 | 2025-06-30 | $1.02B | $15.7M | 1.5% | 0.07 |
| Q1 FY 2025 | 2025-03-31 | $926.9M | -$9.1M | -1.0% | -0.05 |
| Q4 FY 2024derived | 2024-12-31 | $701.2M | -$31.1M | -4.4% | n/a |
| Q3 FY 2024 | 2024-09-30 | $692.4M | -$26.4M | -3.8% | -0.14 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $3.95B | -$724K | $139.9M | $26.8M | n/a | n/a |
| FY 2024 | 2024-12-31 | $2.70B | -$128.0M | $34.8M | $41.4M | n/a | n/a |
| FY 2023 | 2023-12-31 | $1.80B | -$148.0M | -$59.2M | $36.0M | n/a | n/a |
| FY 2022 | 2022-12-31 | $1.43B | -$149.5M | -$45.4M | $23.8M | n/a | n/a |
| FY 2021 | 2021-12-31 | $1.17B | -$195.3M | -$78.8M | n/a | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-27 from the cover page.
What this page is
Alignment Healthcare in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Alignment Healthcare (ALHC), SEC CIK 1832466, listed on Nasdaq, classified by the SEC as hospital & medical service plans. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-28.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-25.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-10.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-05.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-06.JSON and CSV
- Company record
- EDGAR filing index for CIK 1832466Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as hospital & medical service plans
Other company pages
Datasets
Frequently Asked Questions
How much of ALHC is sold short?
25,522,328 shares were held short at the 2026-10-15 settlement, 2.3 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is ALHC's daily short volume?
On 2026-10-28, 649,954 of the 1,671,999 ALHC shares reported to FINRA were sold short, 38.9% of the day's reported volume. Short volume is a flow for one day, not a position.
Does ALHC have fails to deliver?
The SEC's latest file shows 615,856 ALHC shares failed to deliver at settlement 2026-09-25. Fails are reported per settlement date and published twice a month with a lag.
Are ALHC insiders buying or selling?
Insiders at ALHC reported 8 open-market sells worth $13.7M in the last 90 days and no open-market buys. Latest filing: Kim Hyong (Chief Medical Officer) on 2026-10-06.
Have ALHC insiders filed to sell?
45 Form 144 notices on file for ALHC worth $310.5M at the prices reported; 2 in the last 90 days worth $6.6M. Latest: JEK TRUST U/A DTD 02/08/2021 filed on 2026-09-10 to sell 500,000 shares ($6.5M) from 2026-09-10.
Who owns 5% or more of ALHC?
11 holders report 5% or more of ALHC in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 11.3% of the class (23,530,373 shares), filed 2026-10-05 for an event on 2026-09-30.
What did ALHC report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Alignment Healthcare reported revenue of $1.34B, up 31.6% from the same quarter a year earlier, and net income of $36.6M (0.17 diluted EPS). In FY 2025 it generated $139.9M of operating cash flow. As of 2026-06-30, cash was $693.5M against $324.1M of debt.
Which tracked 13F managers own ALHC?
5 of the 30 tracked 13F managers held ALHC shares at their latest filing, $105.5M in all. The largest: Izzy Englander's Millennium Management (1.5M shares, $34.8M), Renaissance Technologies (998K shares, $23.8M), D. E. Shaw & Co. (855K shares, $20.4M), Cliff Asness's AQR Capital Management (594K shares, $14.1M), Two Sigma Investments (519K shares, $12.4M).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.